RadioGraphics
|
|
|
|
Most osteosarcomas occur as primary neoplasms. However, both osseous and soft-tissue osteosarcomas can be secondary lesions (5%-7% of all osteosarcomas) resulting from malignant transformation within a benign process (1). The vast majority of these secondary osteosarcomas are associated with Paget disease (67%-90% of cases) (Figure 18) or previous osseous or extraskeletal irradiation (6%-22%) (1,2,3). The frequency of malignant transformation to osteosarcoma in Paget disease varies widely, from 0.2% in patients with limited involvement to as much as 7.5% in those with extensive skeletal manifestations (96,97). Similarly, the estimates of radiation-induced osteosarcoma show a wide range of prevalence, from 0.02% to 4%, that is related to exposure dose (usually >1,000 cGy) (98,99). Preexisting conditions that less commonly lead to osteosarcoma include osteonecrosis, fibrous dysplasia, metallic implants, osteogenesis imperfecta, chronic osteomyelitis, and retinoblastoma (particularly the familial bilateral type associated with a deficient oncogene suppressor on chromosome 13) (1).
Patients with secondary osteosarcoma are usually middle-aged or in late adulthood, accounting for a small second peak of prevalence in this older age group. Radiologic evidence of the long-standing underlying condition is usually obvious, as is the more aggressive bone destruction in the area of malignant transformation. Large, associated soft-tissue masses are also typical of secondary osteosarcoma (Figure 18).
Pathologically, the lesions are usually composed of high-grade anaplastic tissue and produce little or no mineralized matrix, and this aggressiveness results in a dismal prognosis. Despite all the treatment regimens that have been employed, the 5-10-year survival rate is often extremely poor and less than 5% (1,2,3).
|
|
|
|